Tau-Induced Ca/Calmodulin-Dependent Protein Kinase-IV Activation Aggravates Nuclear Tau Hyperphosphorylation.
10.1007/s12264-017-0148-8
- Author:
Yu-Ping WEI
1
;
Jin-Wang YE
1
;
Xiong WANG
1
;
Li-Ping ZHU
1
;
Qing-Hua HU
1
;
Qun WANG
1
;
Dan KE
1
;
Qing TIAN
2
;
Jian-Zhi WANG
3
Author Information
1. Pathophysiology Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
2. Pathophysiology Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. tianq@mail.hust.edu.cn.
3. Pathophysiology Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. wangjz@mail.hust.edu.cn.
- Publication Type:Journal Article
- Keywords:
Alzheimer’s disease;
CaMKIV;
Nuclear calcium signal;
Phosphorylation;
Tau
- MeSH:
Alzheimer Disease;
metabolism;
pathology;
Calcium;
metabolism;
Calcium-Calmodulin-Dependent Protein Kinase Type 4;
metabolism;
Cell Nucleus;
metabolism;
Enzyme Activation;
physiology;
HEK293 Cells;
Humans;
Neurons;
metabolism;
pathology;
Phosphorylation;
Signal Transduction;
physiology;
tau Proteins;
metabolism
- From:Neuroscience Bulletin
2018;34(2):261-269
- CountryChina
- Language:English
-
Abstract:
Hyperphosphorylated tau is the major protein component of neurofibrillary tangles in the brains of patients with Alzheimer's disease (AD). However, the mechanism underlying tau hyperphosphorylation is not fully understood. Here, we demonstrated that exogenously expressed wild-type human tau40 was detectable in the phosphorylated form at multiple AD-associated sites in cytoplasmic and nuclear fractions from HEK293 cells. Among these sites, tau phosphorylated at Thr205 and Ser214 was almost exclusively found in the nuclear fraction at the conditions used in the present study. With the intracellular tau accumulation, the Ca concentration was significantly increased in both cytoplasmic and nuclear fractions. Further studies using site-specific mutagenesis and pharmacological treatment demonstrated that phosphorylation of tau at Thr205 increased nuclear Ca concentration with a simultaneous increase in the phosphorylation of Ca/calmodulin-dependent protein kinase IV (CaMKIV) at Ser196. On the other hand, phosphorylation of tau at Ser214 did not significantly change the nuclear Ca/CaMKIV signaling. Finally, expressing calmodulin-binding protein-4 that disrupts formation of the Ca/calmodulin complex abolished the okadaic acid-induced tau hyperphosphorylation in the nuclear fraction. We conclude that the intracellular accumulation of phosphorylated tau, as detected in the brains of AD patients, can trigger nuclear Ca/CaMKIV signaling, which in turn aggravates tau hyperphosphorylation. Our findings provide new insights for tauopathies: hyperphosphorylation of intracellular tau and an increased Ca concentration may induce a self-perpetuating harmful loop to promote neurodegeneration.
